Quest Diagnostics Incorporated (DGX) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 2 411 | 3 159 | 1 785 | 1 820 | 1 732 | 1 143 | ||
Changes by years, y/y, % | +52% | +31% | -43% | +2% | -5% | +4.3% |
Quest Diagnostics Incorporated. EBITDA US GAAP, bln rub
Quest Diagnostics Incorporated. EBITDA US GAAP, changes, %
Quest Diagnostics Incorporated. EBITDA US GAAP, sum by quarters, bln rub
Quest Diagnostics Incorporated (DGX) EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | 431.0 | 355.0 | 478.0 | -169.0 | 479.0 | 1 143 | |
Changes by years, y/y, % | +3% | -24% | +3% | -137% | +6% | |||
Changes by quarters, q/q, % | +10% | -18% | +35% | -135% | -383% |